Bone Morphogenetic Proteins Market estimates to grow at a CAGR of 2.1% during the period between 2014 and 2022

The Global bone morphogenetic proteins market is expected to be worth US$587.069 million by 2022. The report, titled “Bone Morphogenetic Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014 - 2022”, assesses the bone morphogenetic proteins market across the globe and estimates the market to grow at a CAGR of 2.1% during the period between 2014 and 2022. The overall market was valued at US$612.601 million in 2013.Bone morphogenetic proteins (BMP) refer to the naturally occurring proteins found in the human body. These proteins are the most potent growth factors that induce mesenchymal cells to differentiate into osteoblast cells. So far, twenty different BMPs have been discovered, of which BMP 2, 7 and 9 have been found to display osteoinductive property for formation of bones. However, only BMP-2 and BMP-7 are commercially available that are involved in synthesizing musculoskeletal tissue formation, matrix, and extracellular growth. 

 

The report points out that the increase in number of spinal fusion surgeries will push the demand for BMPs. Bone-related diseases are common in geriatric population. Rise in ageing population worldwide is expected to trigger the demand from the global bone morphogenetic proteins market. BMPs are required in treating trauma and sports-related injuries. Rising demand for minimally invasive injuries and increasing number of spinal surgeries are expected to propel the global market for BMPs.However, the report points out that the high cost of BMPs and approval for limited indications will restrict the growth of the market. Off-label usage of BMPs is linked to serious side effects which will lead to the decline in market revenue. Availability of alternative bone graft substitutes is also expected to reduce the demand for BMPs in the next couple of years. 

On the basis of the protein types, the report segments the global bone morphogenetic proteins market into recombinant human bone morphogenetic protein-2 (rhBMP-2), and recombinant human bone morphogenetic protein-7 (rhBMP-7). rhBMP-2 has been approved by the U.S. Food and Drug Administration for the treatment of acute and open tibial shaft fractures. rhBMP-7 is used as an alternative for recalcitrant long bone nonunion where autograft or any other treatment is not feasible. In terms of application, the global bone morphogenetic proteins market has been divided into trauma, spinal fusion, oral-maxillofacial, and reconstructive surgery. Spinal fusion surgeries drives the demand from the global bone morphogenetic proteins market. In 2013, in North America, spinal fusion surgeries accounted for 76.5% share in the overall market. 

 

The report studies the bone morphogenetic proteins market in key regional segments such as Asia Pacific, North America, Europe, and Rest of the World. In 2013, North America was the leading region in the market. This can be attributed to the increasing incidences of lower back pain among the patients aged between 40 years and 80 years in the region. Europe closely followed North America as the second largest market for bone morphogenetic proteins in 2013.The report profiles some of the key players in the global bone morphogenetic proteins market such as Medtronic, Stryker Corporation, and Cellumed Co. Ltd. 

 

Browse the full Bone Morphogenetic Proteins Market (Types : rhBMP-2 and rhbmp-7; Applications: Spinal Fusion, Trauma, Reconstructive and Oral - Maxillofacial) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022 report athttp://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

 

The research study has been segmented as below:

 

Global Bone Morphogenetic Proteins Market Revenue, by Types

Global Bone Morphogenetic Proteins Market Revenue, by Application

Global Bone Morphogenetic Proteins Market Revenue, by Geography

About Us

 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

 

Contact

 

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com